Perfuse Therapeutics
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve the vision of patients with ocular diseases.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
14
11 to 50 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
0
tools in use
Monthly traffic
429
organic / mo
Sign up free to see all 8 verified contacts at Perfuse Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- AG
Angela Glendenning
Vice President of Product Development · Science
EmailPhone - KB
Karen Brennan
Vice President, Pharmaceutical Development · Science
EmailPhone - HS
Heather Schmitt
Clinical Development Scientist · Science
EmailPhone - BM
Ben McGraw
Executive Chairman · General Business & Management
EmailPhone - MC
Michelle Chen
Vice President, Head of Clinical Development · Other
EmailPhone - AM
Andrew Melie
Analytical Scientist · Science
EmailPhone - MZ
Maria Zaretskaia
Principal Scientist, Pharmacology & Toxicology · Other
EmailPhone
Showing 7 of 8 verified contacts
Top roles at Perfuse Therapeutics
8 distinct titles indexed · top 8 shown.
- 1analytical scientist
- 1clinical development scientist
- 1executive chairman
- 1principal scientist, device and formulation
- 1principal scientist, pharmacology & toxicology
- 1vice president of product development
- 1vice president, head of clinical development
- 1vice president, pharmaceutical development
Sign up to unlock all 8 contacts at Perfuse Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Perfuse Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.